COVID-19 Vaccination Dashboard
The website is a partnership with UAB and is a vaccination Adverse Events reporting page, in addition to a general COVID-19 vaccination dashboard by VAERS - Health Analytics Team.
COVID-19 and RPC
Connecting Policymakers and Researchers for Children and Families
The Research to Policy Collaboration is actively collecting and disseminating research-informed solutions and resources on the impacts of the coronavirus pandemic on children and families to federal staff and legislators. You can visit our COVID page and review the first issue of our weekly newsletter, Mitigating the Implications of Coronavirus Pandemic on Families. Would you like to be part of this movement? Please join our contact list and share your suggestions for topics for fact sheets, op-ed, policy brief, blog or other communications to Cagla Giray.
COVID Scholar
COVID-19 literature search powered by advanced NLP algorithms
This website uses natural language processing (NLP) to power search on a set of research papers related to COVID-19. It was created by the team behind Matscholar, a research effort led by the HackingMaterials, Persson, and Ceder research groups at Lawrence Berkeley National Lab.
This work is currently funded by a Laboratory Directed Research and Development grant at the Lawrence Berkeley National Laboratory of the US Department of Energy. It was assisted by funding for the development of NLP tools in Materials Science from the Energy Biosciences Institute at UC Berkeley, and from the National Science Foundation.
COVIDScholar was built using computing resources from the National Energy Research Scientific Computing Center (NERSC) and makes use of NERSC's Spin container cloud platform service.
COVID Information Commons
COVID-19 literature search powered by advanced NLP algorithms
Funded by NSF COVID RAPID 2028999, the COVID Information Commons is an open platform to facilitate knowledge sharing and collaboration across various COVID research efforts, especially focusing on NSF-funded COVID Rapid Response Research (RAPID) projects. Join the launch webinar next Wednesday, July 15 from 3-4pm ET. Register at https://bit.ly/CICDemoPhase1. Connection info and presentation materials will be shared with registered participants prior to the event, and a recording will be shared afterward.
Funding Resources
Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
National Institute on Drug Abuse (NIDA)Deadline: Open
NIDA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.
Merck Investigator Studies Program: SARS CoV-2 / COVID-19
MISPDeadline: Open
Effective April 2020, the Investigator Studies Program Review Committee (MISP-RC) will accept proposals within our current areas of interest (AOI) for SARS CoV-2/COVID-19. This is a competitive review process that will be conducted by the SARS CoV-2/COVID-19 MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below.
COVID-19 Early Treatment Fund (CETF)
COVID-19 Early Treatment Fund (CETF)Deadline: Rolling
Top scientists say that the fastest and lowest cost way to end the pandemic is to discover existing drugs that are effective against the virus and prevent hospitalization.
Unfortunately, this sensible approach has attracted far less attention. Most clinical trials for COVID-19 are designed to help hospitalized patients, not to discover drugs that prevent hospitalization. To do the latter, we must test drugs in people as soon as we suspect they are infected. These studies are…
NIH Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations
National Institutes of Health (NIH)Deadline: Standard Dates Apply
The purpose of this Funding Opportunity Announcement (FOA) is to support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters on health care systems serving health disparity populations in communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native…
PCORI Funding Opportunity for COVID-19-Related Enhancements - Research Projects
Patient-Centered Outcomes Research Institute (PCORI)Deadline: On a rolling basis
Existing PCORI-Funded Research Projects
Severe Acute Respiratory Syndrome Coronavirus 2, otherwise known as COVID-19, is a novel respiratory illness that causes complications that can compromise lung function and lead to severe illness or death. COVID-19 imposes significant burdens for patients and their families and has led to acute disruptions in the US healthcare system due to its high incidence, low testing rates, challenging management options, and unknown long-…
PCORI Funding Opportunity for COVID-19-Related Enhancements - D&I Awards
Patient-Centered Outcomes Research Institute (PCORI)Deadline: On a rolling basis
Existing PCORI-Funded Dissemination and Implementation Awards
Severe Acute Respiratory Syndrome Coronavirus 2, otherwise known as COVID-19, is a novel respiratory illness that causes complications that can compromise lung function and lead to severe illness or death. COVID-19 imposes significant burdens for patients and their families and has led to acute disruptions in the US healthcare system due to its high incidence, low testing rates, challenging management…
NIH COVID-19 Funding and Funding Opportunities
National Institutes of Health (NIH)Deadline: Open
As you can imagine, NIH is devoting significant resources to COVID-19. In addition to dedicating regularly appropriated funds, to date NIH has received emergency funding for COVID-19-related activities in two supplemental bills (available from the NIH Office of Budget website)
Promoting Telehealth for Low-Income Consumers; COVID-19 Telehealth Program
Federal Communications Commission (FCC)Deadline: Open
FCC Fights COVID-19 with $200M; Adopts Long-Term Connected Care Study
ICDS Explore Grants for COVID-19 Research
Institute for Computational and Data Sciences (ICDS)Deadline: Open
Provides allocations on ICDS-ACI and hours with RISE team members, who provide advanced compute support.
COVID-19 Research - RAPID
National Science Foundation (NSF)Deadline: Open
NSF encourages the research community to respond to this challenge through existing funding opportunities. In addition, we invite researchers to use the Rapid Response Research (RAPID) funding mechanism, which allows NSF to receive and review proposals having a severe urgency with regard to availability of or access to data, facilities or specialized equipment as well as quick-response research on natural or anthropogenic disasters and similar…
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
National Institutes of Health (NIH)Deadline: Open
The National Institutes of Health (NIH) hereby notify Principal Investigators holding specific types of NIH research grants, listed in the full Funding Opportunity Announcement (FOA) that funds may be available for competitive revisions to meet immediate needs to help address a specific public health crisis in a timely manner, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted. Applications for…
Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19
Agency for Healthcare Research and Quality (AHRQ)Deadline: Open
AHRQ intends to publish a new funding opportunity announcement using the R01 mechanism to support novel, high-impact studies evaluating health system and healthcare professional responsiveness to COVID-19. This Notice is being provided to allow potential applicants sufficient time to develop responsive applications.